A considerable number of patients suffering from aneurysmal subarachnoid hemorrhage (SAH) require mechanical ventilation during the acute phase of their treatment. In approximately 20%, the clinical course of these patients is further complicated by severe pulmonary complications such as pneumonia, pulmonary edema, or acute lung injury, requiring aggressive ventilation strategies (1) . Consequently, physicians are regularly confronted with a unique "lung and brain dilemma," where the ventilatory treatment on the one hand aims at maintaining adequate oxygenation and avoiding hypercapnia and ventilator-induced lung injury and on the other hand has to respect the intracranial pressure (ICP) situation and cerebral blood flow (CBF) status to prevent secondary brain injury. However, little is known about how mechanical ventilation ultimately affects the intracranial compartment.
Based on experimental and clinical experiences, it has become generally accepted that a low tidal volume (6 mL/kg of body weight), FIO 2 Ͻ0.6, and a positive end-expiratory pressure (PEEP) above the lower bend in the pressure-volume curve should be applied to patients with severe lung injury (2) . Especially the application of high PEEP levels has advanced to a mainstay in the treatment of selected patients. Because these patients are suffering not only from severe respiratory failure but also from brain injury, high PEEP levels may have adverse effects on ICP and CBF, causing secondary cerebral ischemia. Although the effects of PEEP on ICP and cerebral perfusion pressure (CPP) have been the focus on several experimental and clinical studies, the results and their interpretation remain controversial (3) (4) (5) . More important, none of these studies has addressed the direct relationship between PEEP, CBF, and cerebral oxygenation.
With the recent advances in neuromonitoring strategies, techniques to continuously assess not only ICP and CPP but also the key variables regional CBF (rCBF) (6) and brain tissue oxygenation (PtiO 2 ) (7) at the patient's bedside have now become available. Therefore, the aim of the present study was to use a multimodal neuro-and hemodynamic monitoring system to investigate the influence of PEEP on ICP, rCBF, and PtiO 2 in a) a healthy porcine model under physiologic Objective: Acute respiratory dysfunction frequently occurs following severe aneurysmal subarachnoid hemorrhage requiring positive end-expiratory pressure (PEEP) ventilation to maintain adequate oxygenation. High PEEP levels, however, may negatively affect cerebral perfusion. The goal of this study was, to examine the influence of various PEEP levels on intracranial pressure, brain tissue oxygen tension, regional cerebral blood flow, and systemic hemodynamic variables.
Design: Animal research and clinical intervention study. Setting: Surgical intensive care unit of a university hospital. Subjects and patients: Experiments were carried out in five healthy pigs, followed by a clinical investigation of ten patients suffering subarachnoid hemorrhage.
Interventions: Under continuous monitoring of intracranial pressure, brain tissue oxygen tension, regional cerebral blood flow, mean arterial pressure, and cardiac output, PEEP was applied in increments of 5 cm 
MATERIALS AND METHODS
Animal Preparation. Experiments were performed in five healthy female pigs (34.6 Ϯ 2.3 kg of body weight). The study was approved by the animal care and use committee of the local government authorities. Anesthesia was induced by ketamine (4 mg/kg of body weight, intravenously) and midazolam (0.25 mg/kg of body weight, intravenously). Animals were tracheotomized and ventilated. Anesthesia was maintained by fentanyl (8 g/kg of body weight/hr) and midazolam (0.5-1 mg/kg of body weight/hr). Neuromuscular paralysis was achieved by vecuroniumbromid (0.05-0.1 mg/kg of body weight/hr). Animals were ventilated in a volume control mode (inspiratory/ expiratory ratio equal to 33%) with constant inspiratory flow and a tidal volume of 6 -7 mL/kg of body weight, adjusted to yield a PaCO 2 of 35-40 mm Hg. FIO 2 was set to 0.4, and PEEP was set to 5 cm H 2 O. During the study, a constant end-tidal CO 2 tension was maintained. A central venous catheter was established through the right internal jugular vein for monitoring of central venous pressure and administration of fluids and drugs. An arterial catheter was inserted into one femoral artery for hemodynamic monitoring and blood gas samplings. Mean arterial blood pressure (MAP) was continuously monitored, and CPP was calculated according to the following equation: CPP ϭ MAP Ϫ ICP. For extended hemodynamic monitoring, a thermistor catheter (Pulsiocath PV 2014L13; Pulsion Medical Systems, Munich, Germany) was advanced into the aorta through the other femoral artery. Body temperature was maintained between 36 and 37°C using a heating pad. An electrolyte solution (5 mL/kg of body weight/ hr) was continuously infused. The animals were turned to the prone position and their head was fixed. Through a frontal burr hole, a sensor for ICP measurement (Codman), a polarographic microprobe for PtiO 2 recordings (Licox, Germany), and a thermal diffusion (TD)-rCBF microprobe (Hemedex) were placed intracerebrally.
Patient Population. The prospective clinical study was approved by the local research ethics committee. Ten patients (two male, eight female) after severe SAH with a mean age of 53 Ϯ 12 yrs and necessitating prolonged mechanical ventilation were entered into the study. Patient characteristics are summarized in Table 1 . All patients had admitted on the day of their bleeding and underwent surgical clipping of their anterior circulation aneurysms the same day. Patients were sedated with midazolam (0.2-0.3 mg/kg of body weight/hr) and fentanyl (4 -8 g/kg of body weight/hr) and paralyzed with vecuronium bromide. They were ventilated in a volume control mode (inspiratory/expiratory ratio equal to 33%) with constant inspiratory flow and a tidal volume of 6 -7 mL/kg of body weight. PEEP was set to 5 cm H 2 O in normal patients (n ϭ 7; body mass index Ͻ25 kg/m 2 ) and to 10 cm H 2 O in obese patients (n ϭ 3; body mass index Ͼ35 kg/m 2 ), and respiration rate was adjusted to maintain a PaCO 2 of 35-40 mm Hg. By analogy with the experimental part a central venous catheter, a radial artery catheter and a 4-Fr thermistor catheter (Pulsiocath PV 2014L13) were placed for hemodynamic monitoring and blood gas samplings. Patients were maintained in 30°head-up position and treated following a standardized ICP-directed management protocol. If required, patients were placed on continuous infusions of noradrenaline for hemodynamic support. At the time of ventriculostomy, the TD-rCBF and PtiO 2 polarographic microprobes were inserted into the vascular territory at risk for developing cerebral vasospasm (8) . Correct probe position was confirmed by a computed tomography (CT) scan. In the same setting, a stable xenon CT (sXe-CT) was performed to validate the TD-rCBF measurements (6, 9) .
Study Protocol. Almost identical protocols were applied to the experimental and clinical parts of the study. In the clinical part, the protocol was performed on days 1, 3, and 7 after SAH. A 30-min accommodation period was allowed before a 15-min baseline recording (MAP, ICP, CPP, PtiO 2 , rCBF, end-tidal CO 2 , cardiac output) was performed. Blood gas analysis and hemodynamic measurements had to reveal physiologic values. After TD-rCBF, ICP, and PtiO 2 signals had stabilized, PEEP was applied in increments of 5 cm H 2 O from 5 cm H 2 O to 25 cm H 2 O and returned to 5 cm H 2 O in the experimental part.
In the clinical part, PEEP was applied in increments of 5 cm H 2 O from baseline (5 or 10 cm H 2 O) to 20 cm H 2 O. In the case that application of 20 cm H 2 O PEEP resulted in a decrease of MAP, infusion of norepinephrine was adapted to increase MAP back to the baseline level. Measurements were taken 10 mins after PEEP was applied and after monitoring variables had stabilized. PEEP was discontinued when CPP decreased below 60 mm Hg, ICP exceeded 25 mm Hg, or rCBF decreased below the critical threshold for cerebral ischemia (i.e., 10 mL/100 g/min in the white matter) (8) . Elevation of ICP caused by PEEP was corrected by cerebrospinal fluid drainage after the measurements were done.
MAP, ICP, CPP, PtiO 2 , rCBF, end-tidal CO 2 , and cardiac output were continuously recorded with a sampling rate of 10 Hz and were calculated by averaging the data samples acquired over 90 secs at the end of each PEEP level. Blood gases, intrathoracic blood volume, extravascular lung water, cardiac index, cardiac function index, and central venous pressure were measured intermittently. Extravascular lung water and intrathoracic blood volume are presented as extravascular lung water index (mL/kg) and intrathoracic blood volume index (mL/m 2 ), respectively. To assess the status of cerebrovascular autoregulation, the cerebral autoregulatory index (AI) was calculated as the ratio of the percentage change in rCBF and the corresponding percentage change in MAP: AI ϭ ⌬rCBF(%)/⌬MAP(%) (10) .
Diagnosis of Vasospasm. In the clinical part, transcranial Doppler sonography was performed daily over the temporal bone windows to assess cerebral hemodynamics. If mean blood flow velocity exceeded 120 cm/sec or increased by Ͼ50 cm/sec within 24 hrs, a cerebral panangiography was performed. In case of negative transcranial Doppler studies, a cerebral panangiography was routinely performed on day 7 after bleeding. A relevant morphologic cerebral vasospasm was defined by an angiographic vessel narrowing Ͼ33%. The diagnostic work-up for vasospasm was further complemented by an sXe-CT study on the day of angiography. In the presence of a mean cerebral blood flow of Ͻ32 mL/100g/ min, hemodynamically relevant cerebral vasospasm was assumed (8, 9, 11) .
Statistics. Descriptive statistics, including mean, SD, and range, were calculated for continuous variables. Analysis of covariance was used to detect possible changes of continuous variables in different groups of PEEP. To detect whether PEEP had an influence on rCBF 
4) (10).
Clinical Part. Complications related to the study protocol were not observed. All patients were normovolemic and normotensive during the study period ( Table 3) . As shown in Table 3 , cardiac index, cardiac function index, intrathoracic blood volume index, and extravascular lung water index remained unchanged during variation of PEEP. In contrast, central venous pressure increased significantly with elevated PEEP levels. Arterial oxygenation and carbon dioxide did not significantly change with higher PEEP levels.
An elevation of PEEP from 5 to 20 cm H 2 O resulted in a statistically significant decrease of MAP and rCBF on all observation time points (Fig. 2, Table 3 ). Analysis of covariance demonstrated that this negative effect of PEEP on rCBF was solely dependent on changes of MAP (range of p values: Ͻ.0001-0.0006). Consequently, after restoring MAP, rCBF normalized as well, despite the persisting increase in PEEP (Fig. 2) . In parallel, on day 1, administration of 20 cm H 2 O PEEP induced a significant decrease of PtiO 2 from 21.3 Ϯ 8.8 to 16.1 Ϯ 9.6 mm Hg, which normalized on restoration of MAP (PtiO 2 ϭ 26.2 Ϯ 3.8 mm Hg). However, on day 3 (33.1 Ϯ 12.7 to 29 Ϯ 12.4 mm Hg) and day 7 (18.5 Ϯ 10.9 to 18.7 Ϯ 12.4 mm Hg), decreases in PtiO 2 were not significant anymore. In contrast to MAP and rCBF, changes in ICP following PEEP manipulation were rather moderate (Fig.  2) . In all patients, baseline ICP was Ͻ20 mm Hg. Elevation of PEEP to 20 cm H 2 O had no significant impact on ICP on days 1 and 3 after SAH. However, ICP increased statistically significant from 11 Ϯ 4 to 19.5 Ϯ 8.9 mm Hg on day 7.
Angiography, sXe-CT studies, and rCBF measurements revealed the presence of hemodynamically relevant vasospasm in six of ten patients on day 7. This allowed us to study whether the influence of PEEP ventilation on cerebral perfusion was affected by the presence of vasospasm-associated hypoperfusion. This subgroup analysis revealed no difference between patients with and without vasospasm, in that MAP and rCBF decreased codependently with increasing PEEP levels and normalized on macrohemodynamic support in both groups.
The MAP-dependent changes of rCBF following PEEP elevation suggested a disturbed cerebrovascular autoregulation in our study population. To test this, we calculated the AI of the patients for each study period, which revealed pathologic values (AI day1 ϭ 1.6 Ϯ 0.8; AI day3 ϭ 1.7 Ϯ 0.7; AI day7 ϭ 1.7 Ϯ 0.7). This disturbance of cerebrovascular autoregulation was comparable among patients with and without vasospasm.
DISCUSSION
Patients with severe SAH are often affected by prolonged respiratory support. Adequate oxygenation and prevention of ventilator-induced lung injury necessitate application of PEEP in various levels. Theoretically, application of high PEEP may induce an increase in ICP through increasing central venous pressure. In parallel, the hemodynamic effects of high PEEP, as reduction of cardiac output and blood pressure, could produce critical reductions in CPP and may lead to cerebral ischemia. So far, the only clinical studies on the effect of PEEP on CBF were performed in healthy volunteers (4, 5, 12) . Furthermore, these studies were limited by the availability of techniques to directly assess rCBF. Thus, these studies failed to reveal the relationship between PEEP and cerebral perfusion in a way that it could be translated into clinical relevance.
In the present study we have characterized the effects of PEEP on cerebral and systemic hemodynamic variables using a multimodal monitoring system that allows for direct comparison of changes in different variables. Integration of continuous rCBF monitoring into the monitoring system has allowed for a direct comparison of PEEP-related changes in rCBF with ICP, PtiO 2 , and systemic hemodynamic variables. To investigate the influence of PEEP on cerebral and hemodynamic variables under physiologic conditions, the experiments were first performed in healthy pigs. Then, the identical monitoring setup and study protocol were used to examine the influence of PEEP on patients following severe SAH. The results of the experimental part demonstrate that PEEP application under physiologic conditions does not affect ICP, rCBF, or PtiO 2 . The results of the clinical part demonstrate that under pathologic conditions, this holds true only as long as the macrohemodynamic variables remain unchanged. This codependency between PEEP and rCBF is the consequence of an impaired cerebrovascular autoregulation following SAH.
Our study failed to reveal a constant correlation between PEEP ventilation and ICP in that we observed a significant increase of ICP on day 7 only. The most likely time range of onset of vasospasm is during days 6 -8 post-SAH. Cerebral vasospasm leads to reduced cerebral blood flow and ischemia, followed by edema formation, which increases cerebral volume. Under normal conditions, the increased cerebral volume can be compensated to some extent by a reduction of the venous or arterial intracerebral blood volume or the CSF fraction. With increasing edema formation, intracerebral compliance decreases. Our patients showed cerebral vasospasm on day 7 after SAH and disturbed autoregulation. It can be assumed that to this time point, cerebrospinal compensatory reserve and intracranial compliance were low and the intracranial pressurevolume curve was steep. Under this condition, any volume-expanding process, as a decreased cerebral venous outflow by PEEP application, may lead to sudden intracranial hypertension. This is partially in accordance with Huseby and coworkers (13) , who stated that PEEP, especially at high levels, may be harmful to patients with impaired cerebral autoregulation because these patients may not tolerate the increased intracranial volume caused by PEEP if they are at the upper end of the intracranial pressurevolume curve. In contrast to Huseby et al., we could not confirm that high PEEP levels led to a refractory ICP increase. Our findings are partially in accordance with the results of the study by McGuire et al. (14) , as we observed no ICP increase in patients with normal ICP on day 1 and 3 after SAH. However, in contrast to the study of McGuire and coworkers, we observed a decrease of MAP and CPP, which is attributable to the higher PEEP levels applied in our study.
PEEP can initiate changes in systemic hemodynamics by increasing intrathoracic pressure, which increases central venous pressure and reduces cardiac filling pressure followed by a reduction in cardiac output. Insufficient circulatory compensation results in a decrease of blood pressure and a reduction of CPP. In patients with an intact cerebral blood flow autoregulation response, MAP reduction can be tolerated without development of cerebral ischemia. However, in SAH patients autoregulation may be impaired, leading to a MAP-dependent cerebral perfusion and higher risk of ischemia (15) . Confirming these observations, all of our patients were characterized by an impaired cerebral autoregulation so that maintenance of MAP was the most important factor to provide sufficient CBF and oxygenation.
We observed a significant increase in central venous pressure and a significant decline of MAP with increasing PEEP levels in the clinical part, which is in accordance with previous findings (13, 16, 17) . The constant cardiac output and cardiac function index point to a systemic circulatory adaptation to the PEEP-induced hemodynamic changes. Nevertheless, circulatory adaptation was obviously not sufficient to maintain MAP. According to the measured cardiac filling volumes, namely the global end-diastolic volume and the intrathoracic blood volume, this was not due to a volume deficiency. Patients suffering from severe SAH present with systemic and cardiovascular problems that might cause unforeseen hemodynamic effects like a systemic vasoregulatory disorder. This is in line with a previous publication suggesting that the sympathetic pathway is impaired in this group (18) . In contrast, a deterioration of the hemodynamic variables with the application of PEEP was not detected in animals. The different interactions between the respiratory and the cardiac system during mechanical positive pressure ventilation seen in animals and patients might be related to the different settings. The experimental part fulfilled a standardized and ideal setting under controlled conditions studying healthy subjects, whereas in patients systemic autoregulation might be impaired.
One limitation of the study is that we only included patients without lung disease. All patients were on mechanical ventilation because of their neurologic deficits, and the results of our study can therefore not directly be extrapolated to lung-injured patients. Nevertheless, we feel that our results can also be applied to patients with low lung compliance because we merely demonstrated that the effects of PEEP on cerebral variables are dependent on the PEEP-induced macrohemodynamic effects, so that PEEP should be applied under monitoring of MAP, ICP, and CPP. As shown by Huseby et al. (13) , stiffer or more edematous lungs protect the intracranial space from the effect of PEEP, so that less compliant lungs have a smaller CPP reduction with PEEP. The application of 20 cm H 2 O PEEP to normal lungs might lead theoretically to pulmonary overdistension. We can't exclude a possible overdistension effect without doubt. However, under stable ventilatory variables (unchanged tidal volume and respiratory rate), we didn't observe any changes in PaCO 2 with increasing PEEP levels, which makes clinically relevant overdistension rather unlikely.
CONCLUSIONS
We have demonstrated that in patients suffering from severe aneurysmal SAH, stepwise elevation of PEEP up to 20 cm H 2 O may cause a significant decrease in MAP, which is often paralleled by a decrease in rCBF as a result of an impaired cerebral autoregulation. Our data suggest that in stable hemodynamic conditions, increased PEEP levels will not impair cerebral perfusion and, therefore, can be applied safely. In neurosurgical patients, application of adequate PEEP should be applied under monitoring of MAP, ICP, and CPP as well as, ideally, some additional surrogate marker for cerebral perfusion.
